AIM: To evaluate the effect of bone marrow-derived mesenchymal stem cells (BMSCs) on ferroptosis in lung injury caused by severe acute pancreatitis (SAP). METHODS: BMSCs were obtained from male SD rats (3 weeks of age). 30 male SD rats (6 weeks of age) were randomly divided into 5 groups: Sham group, SAP group, SAP+PBS group, SAP+BMSCs group, and SAP+BMSCs+ML385 group, with 6 rats in each group. SAP model induced by sodium taurocholate (NaT) was established. Rats in the SAP+MSCs+ML385 group were intraperitoneally injected with ML385 (5 mg/kg) 2h before SAP induction. For PBS control and BMSCs treatment groups, PBS and BMSCs were respectively injected into rats via the tail vein 6 h after creation of the SAP model. All rats were sacrificed 3 days after SAP induction, and pancreas and lung tissue and serum samples were collected. Pancreatic and pulmonary injury was assessed using H&E staining. Serum levels of amylase and lipase and inflammatory factors, as well as tissue levels of iron, malondialdehyde (MDA), glutathione (GSH) were evaluated. The expressions of ferroptosis-associated proteins, including iron responsive element binding protein 2 (IREB2), ferritin heavy chain 1 (FTH1), acyl-CoA synthetase long-chain family member 4 (ACSL4), glutathione peroxidase 4 (GPX4), and solute carrier family 7 member 11 (SLC7A11), as well as the expressions of PI3K/AKT/Nrf2 pathway-related proteins were assessed. RESULTS: The serum levels of amylase, lipase and proinflammatory factors, as well as pathological scores were significantly increased after SAP induction (P<0.05). Changes above were effectively alleviated by BMSCs (P<0.05). Compared with SAP group, the iron and MDA contents were decreased, the GSH activity was increased, the expression of IREB2 and ACSL4 were downregulated and the expression of FTH1, GPX4 and SLC7A11 were upregulated in SAP+BMSCs group (P<0.05). Injection of ML385 partially offset the anti-lipid peroxidation effect of BMSCs (P<0.05). In addition, BMSCs upregulated the total protein levels of PI3K and p-AKT, and the nuclear protein level of Nrf2 in lung tissue (P<0.05). CONCLUSION: BMSCs can effectively reduce systemic inflammatory response and local tissue injury in SAP; BMSCs can inhibit iron deposition and lipid peroxidation in SAP-induced lung injury, and the anti-lipid peroxidation effect may be achieved via activating the PI3K/AKT/Nrf2 signaling pathway.

De novo variants (DNVs) are one of the most significant contributors to severe earlyonset genetic disorders such as autism spectrum disorder, intellectual disability, and other developmental and neuropsychiatric (DNP) disorders. Presently, a plethora of DNVs have been identified using next-generation sequencing, and many efforts have been made to understand their impact at the gene level. However, there has been little exploration of the effects at the isoform level. The brain contains a high level of alternative splicing and regulation, and exhibits a more divergent splicing program than other tissues. Therefore, it is crucial to explore variants at the transcriptional regulation level to better interpret the mechanisms underlying DNP disorders. To facilitate a better usage and improve the isoform-level interpretation of variants, we developed NeuroPsychiatric Mutation Knowledge Base (PsyMuKB). It contains a comprehensive, carefully curated list of DNVs with transcriptional and translational annotations to enable identification of isoformspecific mutations. PsyMuKB allows a flexible search of genes or variants and provides both table-based descriptions and associated visualizations, such as expression, transcript genomic structures, protein interactions, and the mutation sites mapped on the protein structures. It also provides an easy-to-use web interface, allowing users to rapidly visualize the locations and characteristics of mutations and the expression patterns of the impacted genes and isoforms. PsyMuKB thus constitutes a valuable resource for identifying tissue-specific DNVs for further functional studies of related disorders. PsyMuKB is freely accessible at http://psymukb.net.

Objective To explore the effect of ultra early hyperbaric oxygen (HBO) treatment on the permeability of blood-brain barrier in persistent cerebral ischemic rats.Methods 66 healthy SD rats were randomly divided into 11 groups:i.e.the sham surgical group,the cerebral ischemia for 2,4,6,12,24 hours groups and the HBO treatment for 2,4,6,12,24 hours groups,each consisting of 6 rats.The rat model of middle cerebral artery occlusion (MCAO) was developed in the rats of the cerebral ischemia groups and the HBO groups by Longa suture method.Ten minutes after development of the model,the rats in the HBO groups received HBO treatment at a pressure of 0.2 MPa (2.0 ATA) for one hour.The severity of blood-brain barrier damage in the rats of the groups was measured by Evans blue extravagating experiment.Results The permeability of blood-brain barrier reached peak at hour 4 in the rats of the cerebral ischemia group (6.15 ± 1.81).As compared with that of the cerebral ischemia group(6.15 ± 1.81,4.64 ±0.71),the permeability of blood-brain barrier in the rats of the HBO group(3.84 ± 1.26,3.27 ± 0.28) decreased most significantly at hour 4 and hour 12,and there was statistical significance when comparisons were made between the groups(P ＜0.05).Conclusion Ultra early HBO treatment could reduce the permeability of Evans blue extravasation in the brain tissue of the rats with persistent cerebral ischemia,improve blood-brain barrier permeability and protect the blood-brain barrier.The permeability decreased most significantly in the cerebral ischemia rats at hour 4 and hour 12.

Objective To explore the effect of ultra early hyperbaric oxygen (HBO) treatment on the permeability of blood-brain barrier in persistent cerebral ischemic rats.Methods 66 healthy SD rats were randomly divided into 11 groups:i.e.the sham surgical group,the cerebral ischemia for 2,4,6,12,24 hours groups and the HBO treatment for 2,4,6,12,24 hours groups,each consisting of 6 rats.The rat model of middle cerebral artery occlusion (MCAO) was developed in the rats of the cerebral ischemia groups and the HBO groups by Longa suture method.Ten minutes after development of the model,the rats in the HBO groups received HBO treatment at a pressure of 0.2 MPa (2.0 ATA) for one hour.The severity of blood-brain barrier damage in the rats of the groups was measured by Evans blue extravagating experiment.Results The permeability of blood-brain barrier reached peak at hour 4 in the rats of the cerebral ischemia group (6.15 ± 1.81).As compared with that of the cerebral ischemia group(6.15 ± 1.81,4.64 ±0.71),the permeability of blood-brain barrier in the rats of the HBO group(3.84 ± 1.26,3.27 ± 0.28) decreased most significantly at hour 4 and hour 12,and there was statistical significance when comparisons were made between the groups(P ＜0.05).Conclusion Ultra early HBO treatment could reduce the permeability of Evans blue extravasation in the brain tissue of the rats with persistent cerebral ischemia,improve blood-brain barrier permeability and protect the blood-brain barrier.The permeability decreased most significantly in the cerebral ischemia rats at hour 4 and hour 12.